No data available.
COVID-19 Strategic Preparedness and Response Program (SPRP)
Abstract*
The COVID-19 Strategic Preparedness and Response Program is a programmatic framework approach prepared by the World Bank as a global response to the coronavirus (COVID-19) pandemic, using the Multiphase Programmatic Approach. Show More
Development Objective
The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness
Key Details
Project Details
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | N/A |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 4000.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
Detailed Financial Activity as of March 31, 2025
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of countries covered under the Program Value 0.00 91.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Amount of funds disbursed Value 0.00 60.81 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of contracts of COVID-19 disease commodity packages Value 0.00 485.00 150.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of supported countries with pandemic preparedness and response plans Value 0.00 73.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of countries with strengthened early detection capacity (lab, clinical) and isolation (hospital) Value 0.00 74.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of countries with adopted guidelines and plans for health care prevention infection control Value 0.00 74.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of countries with appropriate clinical care guidelines and improved capacity to deal with COVID-19 developed per WHO guidelines Value 0.00 74.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of countries with adopted personal and community non-pharmaceutical interventions (schools closures, telework and remote meetings, reduce/cancel mass gatherings) Value 0.00 59.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of countries with community engagement plans and activities Value 0.00 63.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of countries with social and financial support activities targeted to at risk and vulnerable populations Value 0.00 45.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of countries with outbreak/pandemic emergency risk communication plan and activities developed and tested Value 0.00 62.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of countries with coordinated disease surveillance systems in place to monitor the emergence and re-emergence of zoonotic diseases Value 0.00 25.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Number of countries with mechanisms for responding to the emergence and re-emergence of zoonotic diseases Value 0.00 23.00 50.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Participating countries that have vaccinated their priority population, based on targets defined in their national plans Value 0.00 80.50 70.00 Date April 2, 2020 June 30, 2022 December 31, 2025 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Participating countries with a national plan for Covid-19 vaccine procurement and deployment Value 0.00 81.70 100.00 Date April 2, 2020 June 30, 2022 March 31, 2025 Comment Participating countries with Effective Vaccine Management assessments with composite scores of 80% or higher Value 0.00 30.50 70.00 Date April 2, 2020 June 30, 2022 December 31, 2025 Comment Participating countries with a community engagement plan for increasing demand creation for the Covid-19 vaccine by the population Value 0.00 72.00 70.00 Date April 2, 2020 June 30, 2022 December 31, 2025 Comment